Oceanía · Mercados regionales · Stockhead

Long Shortz with Orthocell: Remplir delivers promising early results in prostate surgery

Publicado por Stockhead · Australia hace 3 h

Early results for Remplir in prostate cancer surgery show 80% of patients recovering urinary continence and 75% maintaining erectile function. ... Read More The post Long Shortz…

Leer el artículo completo en Stockhead Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (stockhead.com.au)

Long Shortz with Orthocell: Remplir delivers promising early results in prostate surgery

También te puede interesar

Landholders and politicians push for tougher laws on renewable energy developments

FROM THE HILL: A snapshot of today's politics and parliament

Here are the top 10 ASX 200 shares today

Bellroy reveals plans for 20 stores as Australian accessories brand goes global with physical retail

Welcome to peak chaos

Escrow plans for existing investors sank Firmus float: report

Long Shortz with Orthocell: Remplir delivers promising early results in prostate surgery

Compartir

También te puede interesar

Landholders and politicians push for tougher laws on renewable energy developments

FROM THE HILL: A snapshot of today's politics and parliament

Here are the top 10 ASX 200 shares today

Bellroy reveals plans for 20 stores as Australian accessories brand goes global with physical retail

Welcome to peak chaos

Escrow plans for existing investors sank Firmus float: report